“A Four-Way, Cross-Over Design, Randomized, Double-Blinded, Placebo-&Active-Controlled Study for the Evaluation of the Effect of a Supratherapeutic Dose of Sofpironium Bromide Gel, 15% Applied Topically on the QT/QTc Intervals in Adult Healthy Volunteers” (2020) SKIN The Journal of Cutaneous Medicine, 4(6), p. s109. doi:10.25251/skin.4.supp.109.